ATE115948T1 - Cyclische vinyloge n-hydroxy-n-methylharnstoffe verwendbar als 5-lipoygenase-inhibitoren. - Google Patents

Cyclische vinyloge n-hydroxy-n-methylharnstoffe verwendbar als 5-lipoygenase-inhibitoren.

Info

Publication number
ATE115948T1
ATE115948T1 AT90113677T AT90113677T ATE115948T1 AT E115948 T1 ATE115948 T1 AT E115948T1 AT 90113677 T AT90113677 T AT 90113677T AT 90113677 T AT90113677 T AT 90113677T AT E115948 T1 ATE115948 T1 AT E115948T1
Authority
AT
Austria
Prior art keywords
methylureas
hydroxy
lipoygenase
vinylog
inhibitors
Prior art date
Application number
AT90113677T
Other languages
English (en)
Inventor
Gary A Flynn
Douglas W Beight
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE115948T1 publication Critical patent/ATE115948T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT90113677T 1989-07-17 1990-07-17 Cyclische vinyloge n-hydroxy-n-methylharnstoffe verwendbar als 5-lipoygenase-inhibitoren. ATE115948T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/380,937 US5026861A (en) 1989-07-17 1989-07-17 Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones

Publications (1)

Publication Number Publication Date
ATE115948T1 true ATE115948T1 (de) 1995-01-15

Family

ID=23503027

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90113677T ATE115948T1 (de) 1989-07-17 1990-07-17 Cyclische vinyloge n-hydroxy-n-methylharnstoffe verwendbar als 5-lipoygenase-inhibitoren.

Country Status (10)

Country Link
US (1) US5026861A (de)
EP (1) EP0409163B1 (de)
JP (1) JP2879464B2 (de)
AT (1) ATE115948T1 (de)
AU (1) AU627339B2 (de)
CA (1) CA2021340C (de)
DE (1) DE69015270T2 (de)
DK (1) DK0409163T3 (de)
ES (1) ES2068952T3 (de)
GR (1) GR3015458T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109010A (en) * 1989-07-17 1992-04-28 Merrell Dow Pharmaceuticals Inc. Dibenzofuranyl substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones
DE4213919A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4213931A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US7937897B2 (en) * 2006-01-25 2011-05-10 Yusenkaisha Japan Isusyc Dome-shaped shelter
WO2010067085A2 (en) * 2008-12-12 2010-06-17 Wista Laboratories Ltd. Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates
WO2012114854A1 (en) 2011-02-21 2012-08-30 Canon Kabushiki Kaisha Heat treatment apparatus and method for manufacturing toner

Also Published As

Publication number Publication date
DK0409163T3 (da) 1995-02-20
DE69015270T2 (de) 1995-06-08
CA2021340A1 (en) 1991-01-18
EP0409163B1 (de) 1994-12-21
AU5900190A (en) 1991-01-17
AU627339B2 (en) 1992-08-20
DE69015270D1 (de) 1995-02-02
JPH0352858A (ja) 1991-03-07
GR3015458T3 (en) 1995-06-30
CA2021340C (en) 2001-01-23
JP2879464B2 (ja) 1999-04-05
ES2068952T3 (es) 1995-05-01
US5026861A (en) 1991-06-25
EP0409163A2 (de) 1991-01-23
EP0409163A3 (en) 1991-03-20

Similar Documents

Publication Publication Date Title
DE59000652D1 (de) Verwendung von umsetzungsprodukten von alkenylspirobislactonen und aminen als paraffindispergatoren.
DE69111596D1 (de) Verwendung von zwitterionen zur mobilisierung isoelektrisch fokussierter ampholytzonen.
DE68911195D1 (de) Wenig klebende Zusammensetzungen von Perfluoropolyether.
DE3889091D1 (de) Härtbare Zusammensetzung von Oxyalkylenpolymeren.
DE3852909D1 (de) Lineare Kette von Parallelprozessoren und Benutzungsverfahren davon.
DE69214882D1 (de) Gerät zur Unterscheidung von Musik und Sprache
DE69415739D1 (de) Verahren und vorrichtung zur schrittweisen bewegung von gegenstaenden
ATA164588A (de) Einrichtung zur kompensation der hochschlagenergie von faustfeuerwaffen
DE3674642D1 (de) Zur modifizierung von bitumen verwendbare polymerzusammensetzungen und so modifizierte bitumenmassen.
DE58906363D1 (de) Verfahren zur Überführung von festen, weitgehend wasserfreien Abfallstoffen in Glasform sowie Vorrichtung zur Durchführung des Verfahrens.
DE69218621D1 (de) Endlosformular und vorrichtung zum herstellen von briefbogen davon
DE69007043D1 (de) Konzentrierungs- und entwässerungsverfahren von schlämmen.
NO910901D0 (no) Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser.
DE68917108D1 (de) Methode des Aufbaus eines optoelektronischen Gehäuses und Vorrichtung.
ES8600404A1 (es) Un metodo para detectar una secuencia seleccionada de acido nucleico en un material biologico.
FR2628429B1 (fr) Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir
ATE115948T1 (de) Cyclische vinyloge n-hydroxy-n-methylharnstoffe verwendbar als 5-lipoygenase-inhibitoren.
EP0616215A3 (de) Verfahren und Einrichtung zur Bestimmung der Reinheit von aufbereitetem Altglas.
FR2659658B1 (fr) Silice traitee par un organosilicone et composition la contenant.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
DE69007449D1 (de) Verfahren zur Herstellung von Leistungsmos- und Halbleiteranordnungen und damit hergestellten Anordnungen.
NO961747D0 (no) Behandling av reumatoid artritt
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
DE69424768D1 (de) Polydioxolanhochmolekulargewichte und herstellungsverfahren
NL192345B (nl) Veelzijdige, uit metaal en/of kunststof bestaande bekledingsplaat.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee